What Is Elidel (pimecrolimus)?

Topical calcineurin inhibitors are medications that are applied to the skin that are used in the treatment of atopic dermatitis (AD). Topical calcineurin inhibitors are usually prescribed as second-line treatment, which means they are used after primary treatment with other topical medications, like corticosteroids, has already been tried and has not sufficiently improved symptoms of AD.1

What is Elidel?

Elidel is a prescription topical medication used to treat mild to moderate AD in adults and children over the age of 2. Elidel should only be used for short-term and non-continuous use in individuals who do not have compromised immune systems and who have already tried other topical treatments for their AD or those who cannot use other treatments.2 The active ingredient in Elidel is pimecrolimus (1%).2

How does Elidel work?

Topical calcineurin inhibitors like Elidel block calcineurin, a chemical naturally produced by the bacteria Streptomyces that activates T-cells. T-cells are a type of white blood cell involved in the immune system response. In AD, there is a dysfunction in the immune system causing excessive inflammation in the skin. Topical calcineurin inhibitors block cytokines (chemical messengers) that trigger the inflammatory response. Once absorbed into the skin, topical calcineurin inhibitors reduce symptoms of AD like redness and itchiness.1,2

What are the possible side effects of Elidel?

The most common side effects experienced by people using Elidel include skin burning, headache, colds, cough, flu, and viral infections. Although no causal relationship has been established, rare cases of cancer (skin cancer and lymphoma) have been reported in patients using topical calcineurin inhibitors including Elidel.2,3

Things to know about Elidel

Topical calcineurin inhibitors like Elidel can be used on any area of the skin, and they are particularly useful in sensitive skin areas, such as the face and skin folds, which may be more susceptible to side effects from topical corticosteroids.1 Elidel should not be used by individuals with a history of hypersensitivity or allergic reaction to pimecrolimus or any components of the cream.2
People with compromised immune systems, including patients taking systemic immunosuppressive medications, should not use Elidel.2

While using Elidel, patients should avoid natural or artificial sunlight exposure, even when the medication is not on the skin.2 Elidel should not be used on skin with malignant or pre-malignant conditions or in patients with a skin barrier defect, such as Netherton’s syndrome.2

It is not known whether Elidel is safe to use during pregnancy. Women who are pregnant or plan to become pregnant should talk to their doctor about the risks and benefits of using Elidel.2

Dosing

A thin layer of Elidel cream is applied to affected areas of skin twice daily. Use of Elidel should be discontinued when the signs and symptoms of AD resolve. If symptoms do not improve within 6 weeks, patients should be re-examined by their doctor.2 Proactive, intermittent application of topical calcineurin inhibitors like Elidel two to three times weekly on areas where AD recurs has been shown to be effective in reducing relapses.1

For additional information on Elidel, read the full prescribing information.

Emily Downward | June 2017
View References